Halozyme (HALO) outlook: acquisitions extend IP beyond 2027, royalties are set to top $1B in 2026, and shares look discounted ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...
Ward 5 Coun. Matthew Scott and Ward 3's Angela Caputo want EpiPen auto-injectors to be as easily accessible as naloxone or ...
Paid Google AI subscribers can ask Gemini to complete tasks, like shopping for party supplies or making an appointment.
Medical Device Network on MSN
The medical device manufacturing crunch
With Covid accelerating time-to-market for medical devices, digital tools play a key role in managing converging priorities ...
The global drug delivery devices market is projected to witness substantial growth driven by the rising prevalence of chronic diseases (diabetes, oncology) and a surge in biologics. The market is ...
Many young patients are being put at risk because they have been prescribed an adrenaline autoinjector device at too low a ...
An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...
Together, Ram and Carrie strengthen Kaléo’s leadership team as the Company continues to support its autoinjector portfolio, advance development programs aligned with emergency preparedness, and ...
The ILUMYA Pen offers eligible patients a safe and effective treatment option that supports ease of use and may help reduce clinical visits through self-administration MUMBAI, India and BRAMPTON, ON, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results